Scott Smith
Net worth: 24 M $ as of 2026-09-29
Net worth: 24 M $ as of 2026-09-29
Mr. Scott A. Smith is a Chief Executive Officer & Director at Viatris, Inc. He is on the Board of Directors at Viatris, Inc., Apexigen America, Inc., Biotechnology Innovation Organization and Himalaya Therapeutics.
Mr. Smith was previously employed as an Independent Director by Apexigen, Inc., a Chairman by F-Star Therapeutics, Inc. (United States), an Independent Director by Titan Pharmaceuticals, Inc., a Chairman by Triumvira Immunologics, Inc., a President & Chief Operating Officer by Celgene Corp., a General Manager by Biovail Pharmaceuticals Canada, a Vice President & General Manager by Biovail Pharmaceuticals LLC, a Head-South East Asia Region by Parke Davis Ltd., a Vice President by Pharmacia Canada, Inc., a Vice President-Sales by Pharmacia Corp., a Vice President-Marketing by Pharmacia SAS, and a Chairman by Triumvira Immunologics USA, Inc. He also served on the board at Refuge Biotechnologies, Inc., BioAtla, Inc. and Aitia, Inc. He received his undergraduate degree from the University of Western Ontario and a graduate degree from Thunderbird School of Global Management.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VIATRIS, INC. 0.12% | 2026-03-25 | 1,329,326 ( 0.12% ) | 24 M $ | 2026-09-29 |
BIOATLA, INC. 0.36% | 2026-05-17 | 5,961 ( 0.36% ) | 7 749 $ | 2026-09-29 |
| Companies | Position | Start |
|---|---|---|
| VIATRIS INC. | Chief Executive Officer | 2023-03-31 |
Himalaya Therapeutics
Himalaya Therapeutics Pharmaceuticals: MajorHealth Technology Develops therapies for cancer patients | Director/Board Member | - |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology | Director/Board Member | 2019-09-04 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Director/Board Member | 2017-05-31 |
| Companies | Position | End |
|---|---|---|
| BIOATLA, INC. | President | 2023-02-26 |
| APEXIGEN, INC. | Director/Board Member | 2023-08-22 |
Refuge Biotechnologies, Inc.
Refuge Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic cells | Director/Board Member | 2021-12-31 |
| TITAN PHARMACEUTICALS | Director/Board Member | 2021-01-07 |
| SPRING BANK PHARMACEUTICALS, INC. | Chairman | 2020-11-19 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 21 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Titan Pharmaceuticals, Inc.
Titan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes proprietary therapeutics for the treatment of serious medical disorders | Health Technology |
Thunderbird School of Global Management
Thunderbird School of Global Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Aitia, Inc.
Aitia, Inc. Miscellaneous Commercial ServicesCommercial Services Provides analytics solutions for the healthcare industry | Commercial Services |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
University of Western Ontario
University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia SAS | |
Biovail Pharmaceuticals LLC
Biovail Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical medicines | Health Technology |
BioAtla, Inc.
BioAtla, Inc. BiotechnologyHealth Technology Develops novel monoclonal antibody and protein therapeutic products | Health Technology |
Pharmacia Canada, Inc. | |
Parke Davis Ltd. | |
F-Star Therapeutics, Inc. (United States)
F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology Engages in discovery, development and preparation of bioavailable therapeutics | Health Technology |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology | Health Technology |
Triumvira Immunologics, Inc.
Triumvira Immunologics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Biovail Pharmaceuticals Canada
Biovail Pharmaceuticals Canada Medical DistributorsDistribution Services Sells pharmaceutical products | Distribution Services |
Refuge Biotechnologies, Inc.
Refuge Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic cells | Commercial Services |
Viatris, Inc.
Viatris, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Triumvira Immunologics USA, Inc.
Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures novel T cell therapies for cancer | Commercial Services |
Apexigen, Inc.
Apexigen, Inc. BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancer | Health Technology |
Himalaya Therapeutics
Himalaya Therapeutics Pharmaceuticals: MajorHealth Technology Develops therapies for cancer patients | Health Technology |
Select your edition
All financial news and data tailored to specific country editions